These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3428142)

  • 1. Quality assurance program for a drug information center.
    Repchinsky CA; Masuhara EJ
    Drug Intell Clin Pharm; 1987 Oct; 21(10):816-20. PubMed ID: 3428142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the accuracy of drug information responses from drug information centers.
    Beaird SL; Coley RM; Blunt JR
    Ann Pharmacother; 1994 Jun; 28(6):707-11. PubMed ID: 7919554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing professional and consumer drug information centers.
    Russello CM; Peterson AM
    Am Pharm; 1993 Nov; NS33(11):49-52. PubMed ID: 8249830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug information quality assurance program used to appraise students' performance.
    Restino MS; Knodel LC
    Am J Hosp Pharm; 1992 Jun; 49(6):1425-9. PubMed ID: 1529983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance program for a drug information center.
    Park BA; Benderev KP
    Am J Hosp Pharm; 1985 Oct; 42(10):2180-4. PubMed ID: 4061459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the dial access drug information service on patient outcome.
    Melnyk PS; Shevchuk YM; Remillard AJ
    Ann Pharmacother; 2000 May; 34(5):585-92. PubMed ID: 10852084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External quality assurance committee for drug information services.
    Smith CJ; Sylvia LM
    Am J Hosp Pharm; 1990 Apr; 47(4):787-91. PubMed ID: 2321653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quality assurance audit of a drug information service.
    Johnson N; Dupuis LL
    Can J Hosp Pharm; 1989 Apr; 42(2):57-61. PubMed ID: 10292922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peer review quality assurance program in drug information.
    Tierney M; Godbout L; Repchinsky C
    Can J Hosp Pharm; 1991 Feb; 44(1):31-4. PubMed ID: 10110041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical approaches to quality assurance of clinical pharmacy programs: a review.
    Rodriguez LR; Weber C
    Top Hosp Pharm Manage; 1988 Feb; 7(4):24-34. PubMed ID: 10314264
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of pharmacist-operated drug information centers in the United States.
    Rosenberg JM; Koumis T; Nathan JP; Cicero LA; McGuire H
    Am J Health Syst Pharm; 2004 Oct; 61(19):2023-32. PubMed ID: 15509125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revising a drug information center quality assurance program to conform to Joint Commission standards.
    Moody ML
    Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Documenting the activity and effectiveness of a regional drug information center.
    Golightly LK; Davis AG; Budwitz WJ; Gelman CJ; Rathmann KL; Sutherland EW; Rumack BH
    Am J Hosp Pharm; 1988 Feb; 45(2):356-61. PubMed ID: 3364436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quality assurance audit for a regional and a hospital drug information service.
    Repchinsky C; Godbout L; Tierney M
    Can J Hosp Pharm; 1988 Oct; 41(5):267-9. PubMed ID: 10290645
    [No Abstract]   [Full Text] [Related]  

  • 15. A drug information service quality assurance audit.
    Hart LL; Miwa LJ; Millares M
    Hosp Formul; 1989 Jul; 24(7):383-6, 388-9. PubMed ID: 10293845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. User satisfaction with services provided by a drug information center in Sudan.
    Fathelrahman AI; Awang R; Bashir AA; Taha IA; Ibrahim HM
    Pharm World Sci; 2008 Dec; 30(6):759-63. PubMed ID: 18704750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of an outcomes information resource. An evaluation of the UK Clearing House on Health Outcomes.
    Greenhalgh J; Long AF; Brettle A; Grant MJ
    J Manag Med; 1996; 10(5):55-65. PubMed ID: 10166033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance in drug information and poison centers: a review.
    Thompson DF; Heflin NR
    Hosp Pharm; 1985 Oct; 20(10):758-60. PubMed ID: 10274171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician perceptions of clinical pharmacy encounters in a family practice clinic.
    Price SO; Newnham MA
    Top Hosp Pharm Manage; 1994 Oct; 14(3):13-20. PubMed ID: 10138924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.